The Rīga Stradiņš University (RSU) mixed choir, Rīga, has returned home with a diploma and the Golden Angel Statuette after winning in the mixed choir category in the Krakow Advent & Christmas Choir Festival in Poland earlier this December.
On 14 December, Rīga Stradiņš University (RSU) management – Rector Prof.
Colistin is a kidney-damaging (nephrotoxic) antibacterial agent. It is currently used in several countries, including Latvia, for critically ill patients due to the spread of multidrug-resistant Gram-negative (Gr-) bacterial infections. Unfortunately, there are currently limited alternatives treating these severe infections. Therefore, special attention should be paid to the proper use of available agents, which includes correct dosing, to minimise the potential development of colistin resistance.
Study Course Description
| Study Course Information | |||||||||
| Course Code: | |||||||||
Few people at Rīga Stradiņš University (RSU) have not heard of Māris Lapšovs (pictured), who is now a 2nd-year resident in cardiology at the Faculty of Residency and a lecturer at the university.
Throughout his undergraduate studies, Lapšovs was active and passionate in everything he did. He was even the Chairperson of the RSU Student Union (Studējošo pašpārvalde, SP) for a year.
| Target audience: | neurologists, paediatric neurologists, general practitioners and other interested parties |
|---|---|
| Time: | 23 March 2024, at 09:00-17:30 |
| Continuing education points: | 12.0 |
| Language: | English |
| Venue: | In person - Rīga Stradiņš U |
Nowadays, multidrug-resistant bacterial infections are on the rise, which means that treatment with antibiotics may not be effective. Bacteriophage therapy is an alternative treatment for bacterial infections.
Bacteriophages or phages are bacterial viruses that enter bacteria, then replicate and kill them. This principle can be used to treat bacterial infections when antibiotics do not have the desired effect.
On 6 December, a celebratory opening of the new Autoimmunity Centre was held at the Riga East Clinical University Hospital (Rīgas Austrumu klīniskā universitātes slimnīca, RAKUS). The centre aims to conduct in-depth scientific research on autoimmune diseases and promote the hospital’s doctors and residents’ involvement in scientific research activities, as well as international collaboration.
Right ventricular failure causes significant limitation of physical activity and impaired quality of life in patients and is a cause of premature death. Treatment options for right ventricular failure are very limited worldwide. It is therefore essential to study and explore new medications and molecules that could potentially improve the function of the right ventricle, and consequently patients’ quality of life and survival rate.
On the occasion of the 10th anniversary of the Rīga Stradiņš University (RSU) Medical Education Technology Centre (METC) on 7 December, RSU signed a memorandum of collaboration with seven healthcare, education, and government institutions.
